From the Desk of Steve Strazza and Alfonso Depablos
The largest insider buy on today’s list comes in a Form 4 filing by Cormorant Asset Management LP.
The investment firm reported the acquisition of 588,235 shares of EyePoint Pharmaceuticals Inc $EYPT, equivalent to roughly $10 million.